Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
VP, Chief Accounting Officer
-
Stock Symbol
-
MRSN on Nasdaq
Ashish Mandelia - trading volume in the past year for Mersana Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
47.8K |
$93.6K |
$1.96 |
Oct 3, 2024 |
Direct |
|
|
Restricted Stock Unit |
16.7K |
$45.2K |
$2.71 |
Jan 15, 2024 |
Direct |
Common Stock |
|
Restricted Stock Unit |
0 |
$0 |
$1.96 |
Oct 1, 2024 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
75K |
|
|
Jan 15, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.